Johnson & Johnson (NYSE:JNJ)‘s stock had its “purchase” score reaffirmed by analysis analysts at Raymond James in a report launched on Friday, AnalystRatings.com experiences.
JNJ has been the subject of a number of different experiences. Credit score Suisse Group lifted their price goal on shares of Johnson & Johnson from $163.00 to $168.00 and gave the stock an “outperform” score in a report on Wednesday, October 14th. ValuEngine upgraded Johnson & Johnson from a “promote” score to a “maintain” score in a analysis notice on Monday, August third. Stifel Nicolaus minimize Johnson & Johnson from a “purchase” score to a “maintain” score in a analysis notice on Wednesday, August 19th. Lastly, Cantor Fitzgerald boosted their price goal on Johnson & Johnson from $168.00 to $180.00 and gave the stock an “chubby” score in a analysis notice on Wednesday, October 14th. One equities analysis analyst has rated the stock with a promote score, 4 have assigned a maintain score and ten have assigned a purchase score to the corporate. Johnson & Johnson has a median score of “Purchase” and a median goal price of $164.93.
Shares of JNJ stock opened at $146.36 on Friday. The corporate has a market cap of $385.30 billion, a P/E ratio of 23.01, a PEG ratio of three.04 and a beta of 0.69. The corporate has a debt-to-equity ratio of 0.51, a present ratio of 1.48 and a fast ratio of 1.24. The stock’s 50-day shifting common is $145.51 and its 200 day shifting common is $146.57. Johnson & Johnson has a 1-year low of $109.16 and a 1-year excessive of $157.00.
Johnson & Johnson (NYSE:JNJ) final launched its quarterly earnings outcomes on Sunday, October 18th. The corporate reported $2.20 earnings per share for the quarter, beating analysts’ consensus estimates of $1.98 by $0.22. Johnson & Johnson had a internet margin of 21.01% and a return on fairness of 34.64%. The enterprise had income of $21.08 billion for the quarter, in comparison with analysts’ expectations of $20.15 billion. Throughout the identical interval final yr, the enterprise earned $2.12 EPS. The corporate’s income was up 1.7% in comparison with the identical quarter final yr. On common, analysts anticipate that Johnson & Johnson will submit 7.99 EPS for the present yr.
In different information, EVP Kathryn E. Wengel offered 16,115 shares of the stock in a transaction on Wednesday, September 2nd. The shares have been offered at a median price of $153.52, for a complete value of $2,473,974.80. Following the sale, the manager vp now owns 66,658 shares within the firm, valued at $10,233,336.16. The transaction was disclosed in a doc filed with the Securities & Change Fee, which could be accessed by way of this hyperlink. 0.27% of the stock is owned by company insiders.
Quite a lot of institutional buyers and hedge funds have just lately made modifications to their positions in JNJ. Kathmere Capital Administration LLC lifted its holdings in Johnson & Johnson by 66.2% throughout the third quarter. Kathmere Capital Administration LLC now owns 4,206 shares of the corporate’s stock valued at $626,00Zero after buying an extra 1,676 shares within the final quarter. Advisor Companions LLC elevated its stake in shares of Johnson & Johnson by 0.4% throughout the third quarter. Advisor Companions LLC now owns 120,497 shares of the corporate’s stock worth $17,940,00Zero after buying an extra 433 shares within the final quarter. Paces Ferry Wealth Advisors LLC acquired a brand new place in shares of Johnson & Johnson throughout the third quarter worth about $1,326,000. Jeppson Wealth Administration LLC bought a brand new place in Johnson & Johnson within the third quarter valued at about $396,000. Lastly, Chiron Capital Administration LLC bought a brand new place in Johnson & Johnson within the third quarter valued at about $134,000. 67.44% of the stock is at the moment owned by institutional buyers.
Johnson & Johnson Firm Profile
Johnson & Johnson researches and develops, manufactures, and sells numerous merchandise within the well being care discipline worldwide. It operates in three segments: Shopper, Pharmaceutical, and Medical Gadgets. The Shopper phase presents child care merchandise beneath the JOHNSON’S model; oral care merchandise beneath the LISTERINE model; magnificence merchandise beneath the AVEENO, CLEAN & CLEAR, DR.
See Additionally: What’s a Purchase-Facet Analyst?
This prompt information alert was generated by narrative science know-how and monetary information from MarketBeat with a view to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial staff previous to publication. Please ship any questions or feedback about this story to cont[email protected]